Omega Healthcare Investors (NYSE:OHI) Receives New Coverage from Analysts at Berenberg Bank

Share on StockTwits

Berenberg Bank assumed coverage on shares of Omega Healthcare Investors (NYSE:OHI) in a report issued on Thursday, The Fly reports. The brokerage issued a buy rating and a $47.00 price objective on the real estate investment trust’s stock.

Other equities analysts have also issued research reports about the company. Wells Fargo & Co increased their target price on Omega Healthcare Investors from $36.00 to $40.00 and gave the company a market perform rating in a research note on Friday, August 23rd. Zacks Investment Research lowered Omega Healthcare Investors from a buy rating to a hold rating in a research note on Wednesday, August 21st. Finally, Raymond James increased their target price on Omega Healthcare Investors from $42.00 to $44.00 and gave the company a strong-buy rating in a research note on Thursday. Seven analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of Hold and an average target price of $40.04.

Shares of OHI opened at $40.52 on Thursday. The company has a quick ratio of 2.78, a current ratio of 2.78 and a debt-to-equity ratio of 1.17. Omega Healthcare Investors has a 12-month low of $31.69 and a 12-month high of $41.67. The firm has a market capitalization of $8.98 billion, a PE ratio of 13.33, a price-to-earnings-growth ratio of 5.45 and a beta of 0.37. The stock’s fifty day simple moving average is $39.02 and its 200-day simple moving average is $37.20.

Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.34 earnings per share for the quarter, missing the consensus estimate of $0.73 by ($0.39). Omega Healthcare Investors had a net margin of 29.38% and a return on equity of 6.79%. The company had revenue of $191.81 million during the quarter, compared to analyst estimates of $190.46 million. During the same period in the previous year, the company posted $0.75 EPS. The company’s quarterly revenue was down .5% compared to the same quarter last year. Analysts anticipate that Omega Healthcare Investors will post 2.96 EPS for the current year.

In other news, insider Michael Ritz sold 5,000 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $40.50, for a total transaction of $202,500.00. Following the sale, the insider now owns 10,485 shares of the company’s stock, valued at $424,642.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO C Taylor Pickett sold 30,000 shares of the firm’s stock in a transaction dated Thursday, June 20th. The stock was sold at an average price of $38.00, for a total value of $1,140,000.00. Following the sale, the chief executive officer now directly owns 299,133 shares in the company, valued at approximately $11,367,054. The disclosure for this sale can be found here. Insiders sold 118,500 shares of company stock worth $4,586,300 in the last three months. Insiders own 1.16% of the company’s stock.

Large investors have recently bought and sold shares of the stock. Coastal Investment Advisors Inc. grew its holdings in shares of Omega Healthcare Investors by 148.4% during the second quarter. Coastal Investment Advisors Inc. now owns 683 shares of the real estate investment trust’s stock worth $26,000 after buying an additional 408 shares in the last quarter. Krane Funds Advisors LLC bought a new position in shares of Omega Healthcare Investors during the second quarter worth about $25,000. Redhawk Wealth Advisors Inc. bought a new position in shares of Omega Healthcare Investors during the second quarter worth about $31,000. Phocas Financial Corp. bought a new position in shares of Omega Healthcare Investors during the second quarter worth about $32,000. Finally, Kavar Capital Partners LLC bought a new position in shares of Omega Healthcare Investors during the second quarter worth about $33,000. Institutional investors and hedge funds own 69.85% of the company’s stock.

About Omega Healthcare Investors

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Further Reading: How does a security become overbought?

The Fly

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Dunelm Group  Stock Rating Upgraded by Peel Hunt
Dunelm Group Stock Rating Upgraded by Peel Hunt
Barclays Downgrades Ferrexpo  to Underweight
Barclays Downgrades Ferrexpo to Underweight
UBS Group Reaffirms “Neutral” Rating for Halma
UBS Group Reaffirms “Neutral” Rating for Halma
Schneider National  Raised to Buy at UBS Group
Schneider National Raised to Buy at UBS Group
Investment Analysts’ Recent Ratings Updates for Mirati Therapeutics
Investment Analysts’ Recent Ratings Updates for Mirati Therapeutics
Sunoco  Upgraded at ValuEngine
Sunoco Upgraded at ValuEngine


 
© 2006-2019 Zolmax.